DE-101 ophthalmic suspension

DE-101 · Santen Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for DE-101 ophthalmic suspension, covering 2011-11-03 to 2012-12-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study Assessing the Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients [Phase 2]